Monday, January 7, 2013

MSFT: Microsoft Is Priced For PC Armageddon

Microsoft Is Priced For PC Armageddon
by Josh Arnold

Overview
Microsoft (MSFT) shares have been mostly range bound for the past three years, oscillating between $24 and $33. At the current price of about $27, shares have fallen precipitously from their March high of $32.95, a decline of greater than 17%. What has caused this decline? What catalysts exist that will get shares back on track? What is Microsoft actually worth? This article will attempt to use qualitative and quantitative evidence to answer these questions and assign a current value to Microsoft shares, given the outlook for future growth. Taking a look at the daily chart below from StockCharts.com, we see that MSFT may be trying to form a base around the $26.50 level, about where it trades now. read more »

More on MSFT

No Signs Of Further Squeeze In Value; Buy Microsoft by Globenum

An Overview Of Microsoft's Key Divisions And Our $42 Valuation by Trefis

U.S. DoD Signs New Deal With Microsoft To Bring Windows 8 To 75% Of Employees by TechCrunch

Other articles that mention MSFT

Intel: Google Partnership Could Pay Off Nicely by Ashraf Eassa

Amazing Returns: Velti, Alcatel-Lucent, Alpha Natural Resources by Tony Pow

Oracle Is Rapidly Converging To Our Fair Value Estimate by Valuentum


Why are you receiving this? You subscribed to real-time article alerts at Seeking Alpha.
If this email was forwarded to you and you wish to subscribe to this email, click here.

Manage your emails:
Get alerts on additional tickers and manage all your email alert choices here
I'm getting too many emails: manage your email alert choices
I'm no longer following MSFT: unsubscribe from all MSFT email alerts
This type of alert isn't helpful to me: unsubscribe from article alerts on MSFT

To ensure you receive these emails in the future, please add account@seekingalpha.com to your address book, contacts or list of safe senders.

Sent by Seeking Alpha, 345 7th Ave. Suite 1400 New York, NY 10001

No comments:

Post a Comment